共 28 条
[1]
Navab M., Ananthramaiah G.M., Reddy S.T., van Lenten B.J., Ansell B.J., Fonarow G.C., Vahabzadeh K., Hama S., Hough G., Kamranpour N., Berliner J.A., Lusis A.J., Fogelman A.M., Thematic review series: The Pathogenesis of atherosclerosis: The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL, J Lipid Res, 45, pp. 993-1007, (2004)
[2]
Miller Y.I., Choi S.H., Fang L., Tsimikas S., Lipoprotein modification and macrophage uptake: role of pathologic cholesterol transport in atherogenesis, Subcell Biochem., 51, pp. 229-251, (2010)
[3]
Glass C.K., Witztum J.L., Atherosclerosis, The road ahead. Cell, 104, pp. 503-516, (2001)
[4]
Palinski W., Rosenfeld M.E., Yla-Herttuala S., Gurtner G.C., Socher S.S., Butler S.W., Parthasarathy S., Carew T.E., Steinberg D., Witztum J.L., Low density lipoprotein undergoes oxidative modification in vivo, Proc Natl Acad Sci USA, 86, pp. 1372-1376, (1989)
[5]
Palinski W., Tangirala R.K., Miller E., Young S.G., Witztum J.L., Increased autoantibody titers against epitopes of oxidized LDL in LDL receptor-deficient mice with increased atherosclerosis, Arterioscler Thromb Vasc Biol., 15, pp. 1569-1576, (1995)
[6]
Hartvigsen K., Chou M.Y., Hansen L.F., Shaw P.X., Tsimikas S., Binder C.J., Witztum J.L., The role of innate immunity in atherogenesis, J Lipid Res, 50 SUPPL., (2009)
[7]
Libby P., Inflammation in atherosclerosis, Nature, 420, pp. 868-874, (2002)
[8]
Rosenfeld M.E., Palinski W., Yla-Herttuala S., Butler S., Witztum J.L., Distribution of oxidation specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits, Arteriosclerosis., 10, pp. 336-349, (1990)
[9]
Tsimikas S., Palinski W., Halpern S.E., Yeung D.W., Curtiss L.K., Witztum J.L., Radiolabeled MDA2, an oxidation-specific, monoclonal antibody, identifies native atherosclerotic lesions in vivo, J Nucl Cardiol., 6, pp. 41-53, (1999)
[10]
Tsimikas S., Shortal B.P., Witztum J.L., Palinski W., In vivo uptake of radiolabeled MDA2, an oxidation-specific monoclonal antibody, provides an accurate measure of atherosclerotic lesions rich in oxidized LDL and is highly sensitive to their regression, Arterioscler Thromb Vasc Biol, 20, pp. 689-697, (2000)